T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HAR
251
DELISTED
Harman International Industries
HAR
| $422M | 0.09% |
3,551,666
+82,540
| +2% | +$10.6M |
|
|
WCG
252
DELISTED
Wellcare Health Plans, Inc.
WCG
| $422M | 0.09% |
4,970,162
+473,097
| +11% | +$40M |
|
253
Ball Corp
BALL
$16.6B
| $418M | 0.09% |
11,931,112
+1,675,290
| +16% | +$60.5M |
|
254
General Mills
GIS
$20.2B
| $416M | 0.09% |
7,467,187
+5,218,146
| +232% | +$292M |
|
255
Dollar General
DG
$26.5B
| $416M | 0.09% |
5,348,009
-42,983
| -0.8% | -$3.24M |
|
256
Corning
GLW
$137B
| $412M | 0.08% |
20,879,673
+172,613
| +0.8% | +$3.69M |
|
257
Stanley Black & Decker
SWK
$15.7B
| $411M | 0.08% |
3,908,049
-1,001,814
| -20% | -$102M |
|
258
Pediatrix Medical
MD
$2.12B
| $411M | 0.08% |
5,544,766
+2,940
| +0.1% | +$212K |
|
259
Microchip Technology
MCHP
$44B
| $411M | 0.08% |
17,312,344
+8,677,744
| +100% | +$211M |
|
260
Digital Realty Trust
DLR
$70.6B
| $410M | 0.08% |
6,144,303
+1,078,698
| +21% | +$70.9M |
|
261
Analog Devices
ADI
$188B
| $409M | 0.08% |
6,373,947
+47,221
| +0.7% | +$3.06M |
|
|
KSU
262
DELISTED
Kansas City Southern
KSU
| $407M | 0.08% |
4,466,533
-1,213,862
| -21% | -$120M |
|
|
MWV
263
DELISTED
MEADWESTVACO CORP
MWV
| $406M | 0.08% |
8,613,326
-1,359,660
| -14% | -$66.7M |
|
264
SLB Ltd
SLB
$79.7B
| $404M | 0.08% |
4,687,946
-2,381,050
| -34% | -$215M |
|
265
Iron Mountain
IRM
$36.4B
| $403M | 0.08% |
12,989,404
+5,981,325
| +85% | +$209M |
|
|
GGP
266
DELISTED
GGP Inc.
GGP
| $401M | 0.08% |
15,627,179
+5,300
| +0% | +$148K |
|
267
Macerich
MAC
$6.96B
| $399M | 0.08% |
5,347,204
+2,182,096
| +69% | +$177M |
|
268
RH
RH
$3.46B
| $398M | 0.08% |
4,077,791
+564,042
| +16% | +$52M |
|
269
DexCom
DXCM
$33.8B
| $398M | 0.08% |
19,887,660
+1,009,888
| +5% | +$17.7M |
|
270
Macy's
M
$6.45B
| $397M | 0.08% |
5,888,821
-414,520
| -7% | -$28M |
|
271
Enovis
ENOV
$1.42B
| $397M | 0.08% |
4,998,387
+118,617
| +2% | +$10M |
|
272
Zurn Elkay Water Solutions
ZWS
$8.6B
| $395M | 0.08% |
34,281,160
-3,273,852
| -9% | -$41.1M |
|
273
Newmont
NEM
$124B
| $393M | 0.08% |
16,834,147
+145,061
| +0.9% | +$3.63M |
|
274
Stryker
SYK
$134B
| $393M | 0.08% |
4,110,486
+298,400
| +8% | +$28.3M |
|
275
Sprouts Farmers Market
SFM
$7.87B
| $392M | 0.08% |
14,528,598
-321,268
| -2% | -$9.86M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.